Integrated Filing (Financial) for the quarter ended 30th June, 2025.
SUMICHEM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sumitomo Chemical India reported strong Q1 FY26 results, with standalone revenue from operations rising about 26% year-on-year to Rs 1,048.07 crore from Rs 831.78 crore in Q1 FY25. Standalone profit after tax grew around 40% to Rs 179.81 crore (vs Rs 128.39 crore), pushing EPS to Rs 3.60 (not annualised) from Rs 2.57. Consolidated results were similar, with revenue at Rs 1,056.78 crore and PAT at Rs 178.10 crore, showing comparable growth. The company noted its business is seasonal and depends on monsoon conditions, and flagged the ongoing Delhi High Court hearing on the 2022 Glyphosate usage notification as a key risk to watch. BSR & Co. LLP issued an unmodified limited review report on both standalone and consolidated results.
A strong quarter with over 25% revenue growth and 40% PAT growth signals healthy operating momentum and margin expansion for shareholders. The unresolved Glyphosate regulatory matter remains a key overhang to monitor but is currently stayed by the court.